Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LPM3770164 extended-release tablets in tardive dyskinesia
CTR20244665Phase 2Completed
- Sponsor
- Luye Pharma Group
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of LPM3770164 in tardive dyskinesia (TD), sponsored by Luye Pharma Group. Started Jan 2025; status: completed.
02
Drugs
LPM3770164
03
Conditions
tardive dyskinesia (TD)
Beyond the preview
Go deeper on CTR20244665.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20244665.